Company news

JCR Pharmaceuticals Co., Ltd. news in 2026

JCR Pharmaceuticals Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

FY2026 Second Quarter Results Briefing Session Material

October 29, 2026

Consolidated Financial Results for the Six Months ended September 30, 2026 (FY2026) (Japanese standard)

October 29, 2026

Italfarmaco and JCR Pharmaceuticals Enter into Exclusive License Agreement for JR-141 in the United States, Europe, and Latin America

October 2, 2026

JCR Pharmaceuticals Receives Orphan Drug Designation from the Ministry of Health, Labour and Welfare of Japan for Givinostat for Duchenne Muscular Dystrophy

September 28, 2026

FY2026 First Quarter Results Briefing Session Material

July 30, 2026

JCR Pharmaceuticals - Notice Regarding the Completion of Payment for the Disposition of Treasury Stock as Restricted Stock Compensation

July 23, 2026

Notice Regarding the Completion of Payment for the Disposition of Treasury Stock as Restricted Stock Compensation

July 22, 2026

JCR Pharmaceuticals Receives Marketing Authorization in the United Arab Emirates for IZCARGO™, a Blood-Brain Barrier-Penetrating Enzyme Replacement Therapy for Hunter Syndrome

July 21, 2026

JCR Pharmaceuticals Announces Development Plan in Japan for Givinostat for Duchenne Muscular Dystrophy

July 14, 2026

Matters Concerning Controlling Shareholders (Affiliated Companies)

June 23, 2026

JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform

June 17, 2026

JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders

February 4, 2026

FY2025 Third Quarter Results Briefing Session - Script（1,742KB）

January 30, 2026

FY2025-Q3 Financial Report (Oct. 1-Dec. 31, 2025)（390KB）

January 28, 2026

JCR Pharmaceuticals to Present at the 22nd Annual WORLDSymposium™ 2026

January 27, 2026

JCR Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 8, 2026

Decks in 2026